| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 4. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | insulin lispro (Humalog® 200 units/ml KwikPen) |
| Formulation | 200 units/ml solution for injection |
| Reference number | 2641 |
| Indication | Treatment of adults with diabetes mellitus who require insulin for the maintenance of normal blood glucose homeostasis. Humalog 200 units/ml KwikPen is also indicated for the initial stabilisation of diabetes mellitus |
| Company | Eli Lilly & Co Ltd |
| BNF chapter | Endocrine system |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 13/03/2015 |